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Novel composites were synthesized from keratin (KER), 
cellulose (CEL) and chitosan (CS). The method is recyclable 
because majority (>88%) of [BMIm+Cl-], an ionic liquid (IL), used 
as the sole solvent, was recovered for reuse. Experimentally, it was 
confirmed that unique properties of each component remain intact 
in the composites, namely bactericide (from KER and CS) and 
anti-inflammatory property (from KER). Specifically, the 
composites were examined for their anti-inflammatory influence 
on macrophages. The cells were imaged and immunophenotyped 
to determine the quantity using the macrophage marker CD11b. 
The 75:25 [KER+CS] composite was found to have the least 
amount of CD11b macrophages compared to other composites. 
Bactericidal assays indicated that all composites, except the 25:75 
[KER+CS], substantially reduce the growth of organisms such as 
vancomycin resistant Enterococcus (VRE) and Eschericia coli. 
The results clearly indicate that the composites possess all 
properties needed for effective use as a wound dressing. 
 
  
Introduction 
 
Non-antigenic keratin is known to possess advantages for wound care, tissue 
reconstruction, cell seeding and diffusion, and drug delivery as topical or implantable 
biomaterial [1-5]. As implantable film, sheet, or scaffold, keratin can be absorbed by 
surrounding tissue to provide structural integrity within the body while maintaining 
stability under mechanical load, and in time can break down to leave neo-tissue. Keratin 
is found to be characteristically abundant in cysteine residues (7-20% of the total amino 
acid residues) [1-5]. These cysteine residues are oxidized to give inter- and intra-
molecular disulfide bond, which results in three-dimensionally linked network of keratin 
fiber.  Interestingly, in spite of its unique structure, keratin has relatively poor mechanical 
properties, and as a consequence, it was not possible to fully exploit unique properties of 
keratin for various applications [1-5].   
 
Polysaccharides such as cellulose (CEL) are known to have strong mechanical 
property [6-8].  Similar to CEL, chitosan (CS), another polysaccharide derived from 
chitin, also has strong mechanical property in addition to its ability to stop bleeding 
(hemostasis), heal wounds, kill bacteria and adsorb organic and inorganic pollutants [6-8]. 
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The information presented is indeed provocative and clearly indicate that adding 
polysaccharide such as CEL and/or CS to KER would substantially enhance the 
mechanical property of the composite to enable it to be used for various applications.  
Such consideration prompted us to initiate this study which aim to improve the 
mechanical properties of the KER composites by adding either CEL or CS to the 
composites, and to demonstrate bactericide and the anti-inflammatory properties of the 
[KER+CEL/CS] composites by quantitating and comparing the relative mean fluorescent 
intensity of macrophage activation using flow cytometry method.  Results of our initial 
investigation are reported herein. 
 
 
Materials and Methods 
Materials.   
 
Chitosan (MW≈310-375kDa), derived from chitin from crustacean shells and 
microcrystalline cellulose (DP≈300) [3], derived from cotton linters, were purchased 
from Sigma-Aldrich (Milwaukee, WI). The degree of deacetylation of chitosan, 
determined by FT-IR, was found to be 84±2 % [5-7].  Raw sheep (untreated) wool, 
obtained from a local farm, was cleaned by Soxhlet extraction using a 1:1 (v/v) 
acetone/ethanol mixture at 80±3 °C for 48 h. The wool was then rinsed with distilled 
water and dried at 100±1 °C for 12 h [9]. 1-Methylimidazole and n-chlorobutane (both 
from Alfa Aesar, Ward Hill, MA) were distilled and subsequently used to synthesize 
[BMIm+CL-] [1]. 
 
The preparation and complete characterization of the [KER+CEL/CS] composite 
materials used in this study was described in our publications [6-8]. Minimal essential 
medium (MEM), 10% Fetal Bovine Serum (FBS) and gentamicin were obtained from 
Atlanta Biologicals, Inc., Lawerenceville, GA. CellTiter 96® Aqueous Non-Radioactive 
Cell Proliferation Assay was obtained from Promega, Madison, WI. 1% Penicillin 
Streptomycin and phorbol 12-myristate 13-acetate (PMA) were obtained from VWR, 
Radnor, PA.  The enzyme-linked immunosorbent assay (ELISA) kit was from R&D 
Systems, Minneapolis, MN and was used according to the manufacturer’s instructions.  
Images of the fibroblasts and macrophages were taken with an Olympus microscopic 
camera using CellSens Imaging Software  (Olympus, Center Valley, PA).   Kendall – 
Curity AMD gauze sponges, 8 and 12 ply (Covidien, Mansfield, MA), Promogran Matrix 
wound dressing (Johnson & Johnson, New Brunswick, NJ), Aquacel and DuoDERM 
CGF (ConvaTec, Princeton, NJ), Allevyn adhesive (Smith + Nephew, Andover, MA) are 
wound dressing material that was purchased commercially. 
 
Bactericidal Activity 
 
Bacterial killing assays were performed in the presence and absence of the 
composites with different compositions and concentrations. The bacterial strains used in 
this protocol included Escherichia coli (ATCC 8739), Staphylococcus aureus (ATCC 
25923), methicillin resistant S. aureus (ATCC 33591) and vancomycin resistant 
Enterococcus faecalis (ATCC 51299).  The strains were maintained on blood agar at 4°C.  
According to a modified protocol from Pinto et. al [10] bacterial cells were grown in 
nutrient broth for 18-20 hr at 37°C with agitation.  The cells were diluted in fresh 
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medium and incubated for 24 hr at 37°C in the presence of the composites.  Serial 
dilutions of the bacteria were plated onto nutrient agar and incubated for 24 hr.  Bacterial 
colony forming units (CFUs) were quantified and compared to bacteria grown in the 
absence of composites. 
 
Cell Culture 
 
The human monocytic cell line THP-1 (ATCC TIB-202) was cultured in RPMI-1640 
medium supplemented with 10% FBS and 1% Penicillin-Streptomycin.  Stimulation and 
differentiation of monocytes to macrophages was performed by adding 0.2 µM phorbol 
12-myristate 13-acetate (PMA) to the medium.  The cell line was maintained under 5% 
CO2 humidified atmospheric conditions in a 37°C incubator.  Composite materials with 
different compositions and concentrations (100% CEL, 75:25 [CEL+KER], 25:75 
[CEL+KER], 100% CS, 75:25 [CS+KER], 25:75 [CS+KER], and 100% KER) were 
incubated with THP-1 cells for three days in the presence or absence of 0.2 mM phorbol 
12-myristate 13-acetate (PMA). Cells without PMA and cells without composite material 
served as the negative controls. THP-1 cells, after 3 days of incubation in various 
combinations, were harvested by scrapping. Cells from each condition were diluted in the 
staining buffer, containing 0.5% bovine serum albumin (Sigma A2153, St. Louis, MO) to 
reduce non-specific binding. The final volume was 1 mL in each condition. Antibody 
staining was carried out by adding 1L CD11b PE (Beckman Coulter Immunotech IM 
2581) into each cell suspension for 20 minutes at room temperature. Without a wash step, 
all tubes were ready for acquisition on a Beckman Coulter Cytomics flow cytometer FC 
500. Data analysis was performed using the CXP flow cytometry software. We defined 
cellular debris based on FSC/SSC dotplot for each condition. The expression of CD11b 
was then displayed on a histogram excluding cellular debris. Mean fluorescence intensity 
(MFI) from CD11b positive populations was used to assess the degree of activation in 
each condition. 
 
Results and Discussion 
 
Mechanical Properties 
 
As described above, in spite of its potentials, applications of KER have not been fully 
realized because it has relatively poor mechanical properties [1-5]. Since polysaccharides 
such as CEL and CS are known to have remarkable high mechanical strength [6-8], it 
may be possible to improve the mechanical property of KER by adding either CEL or CS 
to KER to form composites.  Accordingly, experiments were systematically designed to 
verify effect of addition either CEL or CS on the tensile strength of the resultant 
[KER+CEL/CS] composites. Figure 1 plots tensile strength of [KER+CEL] and 
[KER+CS] composite as a function of CEL and CS content, respectively. As illustrated, 
the tensile strength of [CEL+KER] composite films was found to increase concomitantly 
with the content of CEL. For example, the tensile strength of [KER+ CEL] increased by 
at least 4X when CEL loading was increased from 25% to 75%. It is worth noting that 
[KER+CEL] composites are relatively weaker than [CS+CEL] composites which we 
synthesized previously [6]. For example, [CEL+KER] and [CEL+CS] containing 75% 
and 71% CEL had tensile strengths 36±3 MPa and 52 MPa respectively. This could be 
attributed to the fact that CEL structure is more similar to that of CS than to KER 
structure. Therefore relatively stronger interactions may be possible between CEL and CS 
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than between CEL and KER.  Although CS also leads to an increase in the tensile 
strength of [KER+CS], its effect is noticeably weaker than that of CEL of comparable 
loading. For example, [CEL+KER] and [CS+KER] had tensile strength values of 37±6 
MPa and 20±1 MPa respectively for a 40% KER loading. This is hardly surprising 
considering the fact that CS is inherently weaker than CEL as can be seen by the tensile 
strengths of 100% CS (36±9 MPa) and 100% CEL (82±4 MPa).  It is noteworthy to add 
that 100% KER was too brittle to measure the tensile strength. 
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Figure 1.  Plot of tensile strength as a function of CEL and CS concentration, respectively 
in [KER+CEL] composites (blue curve) and [KER+CS] composite (black curve). 
 
 
 
Anti-inflammatory Properties 
 
CD11b expression is known to be one of the activation markers for monocytes [11].  
Furthermore, density of the CD11b molecules on cell surface can be determined by 
measuring MFI as MFI is known to be a reliable indicator for the density of the CD11b.  
Accordingly, by using digital imaging and immunophenotyped macrophages to quantitate 
CD11 through MFI, it was possible for us to determine the anti-inflammatory effect of 
the composite materials.  As expected, it was found that MFI increased significantly 
following PMA treatment in THP-1 cell line. As MFI is a reliable indicator for the 
density of CD11b molecules on cell surface, higher MFI values indicating more CD11b 
molecules on cell surface, or more inflammation. The histograms displaying CD11b 
fluorescence from mitogen stimulated monocytes is shown in Figure 2. As shown in the 
figure, the presence of KER and/or CS decreased CD11b values while CEL maintained 
the same CD11b value as cells treated with PMA.  Among all composites tested, the least 
amount of CD11b macrophages was found in the presence of the 75:25 [CS+KER] 
composite whereas the 100% CEL composite brought the highest amount of CD11b 
macrophages.  The results seems to indicate that KER and/or CS can effectively serve as 
anti-inflammatory agents. 
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Figure 2.  Histograms displaying CD11b fluorescence from mitogen stimulated 
monocytes. PMA-stimulated monocytes were incubated with (A) [CEL+KER] composites and 
          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Antibacterial Properties 
 
We have previously shown that [CEL+CS] composites can effectively inhibit the 
growth of both Gram positive and negative microorganisms [6-8].  For examples, the 
100% chitosan material was found to reduce growth of Escherichia coli (ATCC 8739) 
and vancomycin resistant Enterococcus faecalis (ATCC 51299) (VRE) by 78% and 64%, 
respectively [8].  Since KER also known to possess antimicrobial activity [1-5,12,13], it 
is important to determine if KER retains its bactericide upon regenerated and formed 
composites chitosan.  Accordingly, antimicrobial assay of [CEL+KER] and [CS+KER] 
composites were performed and the results obtained are shown in Figure 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.  Bacterial activity of composites.  VRE (blue) and E. coli (purple) were cultured in 
the presence and absence of composites with different compositions and concentrations.  
The % growth reduction represents the CFU/mL of bacteria divided by the CFU/ml of the 
standard bacterial growth (i.e., no composite)X100.  Each experiment was performed at 
least three independent times and the error bars represent standard deviation. 
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To assess the antimicrobial activity of the [KER+CEL/CS] composites, bacteria were 
grown in the presence of the composites for 24 hours.  The cultures were then plated onto 
nutrient rich media and colony forming units were counted and compared to the standard 
growth control.  The results for the percent growth reduction of VRE and E. coli in the 
presence of the composites are presented in Figure 3.  As illustrated, the composites 
containing CS had the greatest effect on reducing the growth of VRE.  Moreover, it 
should be noted that all of the composites reduced the growth of VRE.  The most 
effective antimicrobial activity against E. coli included those composites with 100% KER, 
100% CS and 75:25 [KER+CS].  It is noted that the reduction in E. coli correlated with 
the amount of CS in the composite, the more CS present, the greater is the reduction.  
While the 100% KER composite also had a great effect on E. coli growth, although some 
of the activity was lost when combined with CEL or CS, especially the 25:75 [KER+CS] 
composite.  Experiments are currently under progress to investigate this discrepancy. 
 
 
Conclusions 
 
In summary, we have successfully synthesized novel, biocompatible and 
biodegradable composite materials from CEL, CS and KER.  We have experimentally 
confirmed that unique properties of each component remain intact in the composites.   
Specifically, results of tensile strength measurements clearly indicate that adding CEL or  
CS into KER substantially increases tensile strength of the composites.  The tensile 
strength of [KER+CEL/CS] composites was found to increase concomitantly with the 
content of CEL or CS.  For example, the tensile strength of [KER+ CEL] increased by at 
least 4X when CEL loading was increased from 25% to 75%.  The tensile strength of the 
composite material can be adjusted to any value by adding judicious amount of either 
CEL or CS. Anti-inflammatory effect of the composites, determined by cytometry 
through immunophenotyped macrophages to quantitate CD11 indicate that the presence 
of KER and/or CS enable the composite effectively serve as an anti-inflammatory agents.  
Results of in vitro antibacterial assays confirm that unique properties of CS and KER 
remain intact in the material, namely, the composite material retain its antibacterial 
property.  The [KER+CEL/CS] composites can effectively inhibit growth of VRE and E. 
coli.  Taken together, the results obtained clearly indicate that the composites possess all 
properties needed for effective use as a wound dressing. 
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